思派健康2023 中期报告

2 6 8 21 36 38 40 42 44 47 75 CORPORATE INFORMATION BOARD OF DIRECTORS Executive Directors Mr. MA Xuguang(Chairman of the Board)Mr. LI Ji Non-executive Directors Mr. YAO LeiwenMr. ZHANG Ziquan(resigned on May 10, 2023) 20235 10 Independent Non-executive Directors Mr. CHANG Stanley Yi, aliasMr. FAN Xin(appointed on May 10, 2023)Mr. HE HaijianMs. HUANG Bei CHANG Stanley Yi20235 10 REMUNERATION AND APPRAISAL COMMITTEE Mr. HE Haijian(Chairman)Ms. HUANG BeiMr. LI Ji NOMINATION COMMITTEE Mr. MA Xuguang(Chairman)Mr. CHANG Stanley Yi, aliasMr. FAN Xin(appointed on May 10, 2023)Mr. HE Haijian CHANG Stanley Yi20235 10 AUDIT COMMITTEE Mr. CHANG Stanley Yi, alias(Chairman) CHANG Stanley Yi20235 10 Mr. FAN Xin(appointed on May 10, 2023)Mr. HE HaijianMs. HUANG Bei STRATEGY COMMITTEE Mr. MA Xuguang(Chairman)Mr. LI JiMr. YAO LeiwenMr. ZHANG Ziquan(resigned on May 10, 2023) 20235 10 C O R P O R A T E I N F O R M A T I O N JOINT COMPANY SECRETARIES Ms. REN NaMs. LI Ching Yi(appointed on March 13, 2023)Ms. TSANG Wing Man(resigned on March 13, 2023) 20233 1320233 13 AUTHORISED REPRESENTATIVES Mr. LI JiMs. LI Ching Yi(appointed on March 13, 2023)Ms. TSANG Wing Man(resigned on March 13, 2023) 20233 1320233 13 COMPLIANCE ADVISER Alliance Capital Partners LimitedUnit 03, 7/FWorld Wide House19 Des Voeux Road CentralHong Kong 19703 COMPANY WEBSITE www.medbankshealthtech.com www.medbankshealthtech.com REGISTERED OFFICE Campbells Corporate Services LimitedFloor 4, Willow House, Cricket SquareGrand Cayman KY1-9010Cayman Islands Campbells Corporate Services LimitedFloor 4, Willow House, Cricket SquareGrand Cayman KY1-9010Cayman Islands C O R P O R A T E I N F O R M A T I O N PRINCIPAL PLACE OF BUSINESS IN THE PRC 7/F, Building 3Xingguangyao PlazaNo. 1888, Caoyang RoadPutuo District, ShanghaiPRC 188837 PRINCIPAL PLACE OF BUSINESS IN HONG KONG 14th Floor, Golden Centre188 Des Voeux Road CentralHong Kong 18814 PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE Campbells Corporate Services LimitedFloor 4, Willow House, Cricket SquareGrand Cayman, KY1-9010Cayman Islands Campbells Corporate Services LimitedFloor 4, Willow House, Cricket SquareGrand Cayman, KY1-9010Cayman Islands HONG KONG BRANCH SHARE REGISTRAR Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong 1617 C O R P O R A T E I N F O R M A T I O N LEGAL ADVISERS As to Hong Kong and U.S. laws 131 O’Melveny & Myers31/F, AIA Central1 Connaught Road CentralHong Kong As to PRC law 77334 Jingtian & Gongcheng34/F, Tower 3, China Central Place77 Jianguo RoadChaoyang District, BeijingPRC As to Cayman Islands law Campbells1301, 13/FYork House, The Landmark15 Queen’s Road CentralHong Kong Campbells15131301 AUDITOR Ernst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditors27/F One Taikoo Place979 King’s RoadQuarry BayHong Kong 97927 STOCK CODE 03140314 FINANCIAL SUMMARY Notes: 1.Items (non-IFRS measure) exclude share-based payment compensation andListing expense.2.We do not consider fair value loss on convertible redeemable preferredshares, share-based payment compensation, and Listing expenses (asnon-operational or non-recurring expenses) will affect our ongoing operatingperformance. This is presented in accordance with the non-IFRS measures,for details, please refer to the subsection headed “Non-IFRS Measures” in thisinterim report.3.Items include share-based payment compensation in selling and marketingexpenses, administrative expenses, and research and development expenses.4.Cash and selected financial assets include cash and cash equivalents, timedeposits over three months, pledged deposits, and wealth managementproducts which are presented in financial assets at fair value through profit orloss (“FVTPL”) in financial statement.5.“n/m” denotes “not meaningful”. 1.2.3.4.5.n/m MANAGEMENT DISCUSSION AND ANALYSIS BUSINESS REVIEW AND OUTLOOK During the first half of 2023, we continued to focus on achievingorganic growth and operational efficiency improvement in ourcore business, while maintaining our ongoing investment in overalldigitalization and synergy development. The Group’s unaudited revenuefor the six months ended June 30, 2023 increased by approximately29.2% to approximately RMB2,437.96 million as compared to thecorresponding period of last year, while loss attributable to ordinaryequity holders of the parent for the six months ended June 30, 2023decreased by approximately 73.3% to approximately RMB92.32 millionas compared to the corresponding period of last year. The Group’snon-IFRS loss attributable to ordinary equity holders of the parent forthe six months ended June 30, 2023 decreased by approximately73.4% to approximately RMB38.20 million as compared to thecorresponding period of last year. 202320236 3029.2%2,437.96202363073.3%92.32202363073.4%38.20 Our Services We currently run three business lines, including specialty pharmacybusiness (the “